Prostatic disorders in the dog

被引:138
作者
Johnston, SD
Kamolpatana, K
Root-Kustritz, MV
Johnston, GR
机构
[1] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA
[2] Kasetsart Univ, Fac Vet Med, Nakhon Pathom 73140, Thailand
[3] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA
关键词
canine prostatic hypertrophy; canine prostatitis; canine prostatic neoplasia; finasteride;
D O I
10.1016/S0378-4320(00)00101-9
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Common canine prostatic disorders include benign prostatic hypertrophy (BPH), prostatitis, prostatic cysts and prostatic adenocarcinoma. BPH is a spontaneous and age-related disorder of intact male dogs, which occurs in more than 80% male dogs over 5 years of age, and which is associated with clinical signs of sanguinous prostatic fluid, constipation and dysuria. BPH signs respond to castration or to finasteride treatment (0.1-0.5 mg/kg per os once daily), as finasteride inhibits conversion of testosterone to dihydrotestosterone, causing prostatic involution via apoptosis. BPH often occurs concurrently with prostatic infection, abscessation, cysts and neoplasia in the intact dog, and finasteride-induced prostatic involution may be beneficial in treatment of all of these conditions except neoplasia. Two studies suggest that risk of prostatic adenocarcinoma is increased in neutered, compared to intact male dogs. Although canine prostatic neoplasia, unlike human prostatic neoplasia, usually does not respond to androgen deprivation, recent reports of prostatic intraepithelial neoplasia (PIN) in a high percentage of older male dogs, with and without prostatic adenocarcinoma, suggests that PIN may be a precursor to adenocarcinoma in the dog as it is believed to be in man. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:405 / 415
页数:11
相关论文
共 38 条
[1]  
BAMBERGTHALEN B, 1993, J AM ANIM HOSP ASSOC, V29, P221
[2]  
BARSANTI JA, 1983, J AM VET MED ASSOC, V183, P219
[3]  
BARSANTI JA, 1995, CURRENT VET THERAPY, V12, P1033
[4]  
BASINGER RR, 1987, COMP CONT EDUC PRACT, V9, P993
[5]  
BELL FW, 1991, J AM VET MED ASSOC, V199, P1623
[6]   EVALUATION OF SERUM AND SEMINAL PLASMA MARKERS IN THE DIAGNOSIS OF CANINE PROSTATIC DISORDERS [J].
BELL, FW ;
KLAUSNER, JS ;
HAYDEN, DW ;
LUND, EM ;
LIEBENSTEIN, BB ;
FEENEY, DA ;
JOHNSTON, SD ;
SHIVERS, JL ;
EWING, CM ;
ISAACS, WB .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 1995, 9 (03) :149-153
[7]   COMPARISON OF THE EFFECTS OF NEW SPECIFIC AZASTEROID INHIBITORS OF STEROID 5-ALPHA-REDUCTASE ON CANINE HYPERPLASTIC PROSTATE - SUPPRESSION OF PROSTATIC DHT CORRELATED WITH PROSTATE REGRESSION [J].
COHEN, SM ;
WERRMANN, JG ;
RASMUSSON, GH ;
TANAKA, WK ;
MALATESTA, PF ;
PRAHALADA, S ;
JACOBS, JG ;
HARRIS, G ;
NETT, TM .
PROSTATE, 1995, 26 (02) :55-71
[8]  
CORNELL KK, 1997, P ANN M AM COLL VET, P86
[9]  
COWAN LA, 1991, J AM VET MED ASSOC, V199, P346
[10]  
DORFMAN M, 1995, AM J VET RES, V56, P386